Material safety data sheet

MATERIAL SAFETY DATA SHEET
Product # 20057
King Home & Garden Inc.
__________________________________________________________________________ GARDAL ROSE, FLOWER AND EVERGREEN DUST
_____________________________________________ SECTION I - REGULATORY INFORMATION
__________________________________________________________________________ TRADE NAME:
WHMIS CLASSIFICATION: EXEMPT
PCP No. 14851, registered 19 January 2007
CHEMICAL CLASS: Organophosphorus and carbamate insecticide plus a benzimidazole and captan fungicides.
PRODUCT USE: Insect and plant disease control agents at low concentrations in talc to use as a dust.
____________________________________________________________________________ SECTION II - FIRST AID MEASURES
____________________________________________________________________________ IF POISONING IS SUSPECTED or any symptoms are serious, immediately contact a doctor, the nearest
hospital, or the nearest poison control centre. Give the complete product name, describe what happened and follow
the advice given.
EYES:
Flush eyes with clean water for 5 - 10 mins. holding eyelids apart and obtain medical Remove contaminated clothing and wash skin, hair and fingernails thoroughly with soap and water. Obtain medical attention if irritation occurs. Wash contaminated clothing before reuse.
INHALATION:
Move to fresh air, clean up, and rest. Apply artificial respiration if necessary.
IN MOUTH:
If swallowed give the patient 1 to 2 glasses of water and cause vomiting by giving one dose of syrup of ipecac or if syrup of ipecac is not available, and cause vomiting by inserting a finger down the throat. Repeat with water until vomit is clear. NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON. Apply artificial respiration if necessary. Call a doctor or poison control centre immediately.
NOTE TO PHYSICIAN: Treat according to symptoms. Monitor serum and RBC cholinesterase. Atropine is an
antidote for cholinesterase effects. Morphine, theophylline, aminophylline, phenothiazines, reserpine, furosemide or ethacrynic acid are contraindicated in
MEDICAL CONDITIONS LIKELY TO BE AGGRAVATED BY EXPOSURE:
Exposure to cholinesterase inhibitors should be restricted in persons with hemolytic anemias or preexisting
cholinesterase depression. Persons with respiratory disorders or allergy to thiophanate methyl and/or captan should
use extra care in handling this product.
____________________________________________________________________________
SECTION III - FIRE AND EXPLOSION HAZARD
___________________________________________________________________________
FLASH POINT: not applicable
AUTOIGNITION TEMP: not applicable
HAZARD LEVEL: Non-Flammable Solid
FLAMMABLE LIMITS IN AIR (% by volume):
EXTINGUISHING MEDIA: All are compatible. Avoid excessive water.
SPECIAL FIRE FIGHTING PROCEDURES: All personnel exposed to smoke or fumes must wear a
pesticides respirator or self-contained breathing apparatus and full protective clothing. Evacuate all nonessential
personnel and animals. Control discharges to the environment as quickly as possible. Prevent use of buildings, area
and equipment until properly decontaminated.
UNUSUAL FIRE AND EXPLOSION HAZARDS: Toxic, flammable fumes are released by thermal
decomposition in a fire. The product is not impact or shock sensitive, and risk of dust explosion is low.
HAZARDOUS COMBUSTION OR DECOMPOSITION PRODUCTS: Thermal decomposition products
may include toxic organophosphates, carbon monoxide and hydrogen cyanide.
___________________________________________________________________________
SECTION IV - REACTIVITY DATA
____________________________________________________________________________
Chemical Stability: Stable at temperatures below 40C
Unstable conditions: Decomposition of carbaryl and malathion will occur above 40°C.
Incompatible substances: strong acid or alkali
Hazardous polymerization: will not occur
Conditions contributing to hazardous reactivity: flame, heat and ignition sources.
Corrosivity: noncorrosive
____________________________________________________________________________
SECTION V - PHYSICAL DATA
__________________________________________________________________________ APPEARANCE AND ODOUR: Off-white fine powder, sulphur/cabbage odour.
PHYSICAL STATE: solid
VISCOSITY: not applicable
SPECIFIC GRAVITY: not available
BULK DENSITY: not available
BOILING POINT: not applicable
MELTING POINT: decomposes
pH: not applicable
ODOUR THRESHOLD: not available
VAPOUR DENSITY: non volatile
PER CENT VOLATILE: less than 1
EVAPORATION RATE: non volatile
SOLUBILITY IN WATER: product is insoluble.
OCTANOL/WATER PARTITION COEFFICIENT:
log P carbaryl: 2.36; captan 2.35; malathion 2.36 HENRY'S LAW CONSTANT:
ai: carbaryl: 1.28 X 10-8; captan: 5.9 X 10-6; malathion: 2 X 10-8 atm-m³/mol at 20°C (estimated). ________________________________________________________________________ SECTION VI - TOXICOLOGICAL PROPERTIES
_________________________________________________________________ ACUTE TOXICITY - UNDILUTED: (immediate effects of a single overexposure).
Swallowing 1 ounce of the dry powder can cause serious illness for an adult, but death is not likely. Careless use or
accident leading to a) excessive inhalation of dust, mist or vapour, or b) product or spray mix dumped directly on the
face and in mouth can also cause illness. The powder causes irritation on contact with skin or eyes. Allergies or
dermatitis are known to occur with captan, particularly after repeated overexposure on skin. It is not possible to obtain
a harmful dose of this product after it is applied.
TECHNICAL DETAILS WITH HAZARD LEVELS ACCORDING TO PCP ACT
CLASSIFICATION:

Oral LD50 Rat >6,000 mg/kg; inhalation LC50 Rat exceeds 10,000 mg/L (Calculated on LC50s of active ingredients)
Dermal LD50 Rat >3100 mg/kg, slightly toxic.
EXPOSURE LIMITS: ACGIH

CHRONIC TOXICITY - ACTIVE INGREDIENT (ai) AND OTHER INGREDIENTS:
(The delayed or long term exposure effects)
Carbaryl and malathion products are not known to produce any unavoidable ill effects after repeated exposure or over
a long period of time. The health effects of these ingredients are almost entirely the result of inhibition of an enzyme,
cholinesterase, which assists in transmitting signals between nerve cells. There is no damage to the nerves
themselves. Captan affects cell metabolism, and inhibits use of energy, and cell division at high dose levels, but is so
insoluble that it is poorly absorbed through the skin or from the intestines. All three active ingredients are rapidly
broken down and eliminated from the body, with no long term accumulation.
Carbaryl or malathion do not cause cancer or tumours, and caused no mutagenicity or genetic damage in lab tests.
The active ingredients had no effect on the reproductive capability of rats over two generations (captan, 3 generations),
and caused no birth defects (teratogenicity) in rats or rabbits. Captan also caused no birth defects in dogs or monkeys,
but was teratogenic in hamsters. For humans, there is no risk of any effects on the fetus or later generations from the
dose levels obtainable from this product.
A special hazard-warning label is required on the label of Canadian products containing captan, because it has caused
tumours in one of three strains of mice at high dose levels. It did not cause tumours in rats, or other animal tests, and
two studies showed it inhibited tumour growth and prolonged the life of mice with cancer. Some research agencies
consider captan a carcinogen, others, like ACGIH do not. The cancer risk from normal use of this product is not
significant.
The mutagenicity of captan to simple organisms like bacteria or yeast, or to isolated cells is rapidly detoxified by the
presence of blood or in whole animals. Tests in humans showed no genetic damage in production workers.
Interaction with other chemicals is limited by low toxicity, poor uptake and extensive breakdown of the ingredients in
the gut before absorption. The ingredients do not interact to increase toxic effects. Sensitization to captan on skin is
greatly increased by polyethylene glycol, and slightly increased by lanolin/Vaseline.
Thiophanate Methyl is not considered to be a carcinogen or oconogen. The No Adverse Effect Level in 2 year feeding
studies in rats and mice was 160 ppm in the diet and in dogs it was 50 ppm. Thiophanate Methyl had no adverse
effects on the ability of rats to reproduce in a 3-generation reproduction study at levels to 160 ppm in the diet. Higher
levels reduced growth. Thiophanate Methyl was not teratogenic in rats or mice and was not mutagenic in standard test
systems.

OVEREXPOSURE EFFECTS:

ACUTE:
Eye and skin contact cause irritation. Inflammation or skin rash may occur. Breathing dust may cause irritation or inflammation of lungs, and headache. Swallowing large amounts may cause discomfort, inflammation or bleeding in stomach or intestines, diarrhea, vomiting, cramps, and pinpoint pupils.
CHRONIC:
Exposure levels, which could be obtained with normal handling or use of this product, are too low to cause any risk of long term or delayed health effects. Some individuals may develop an allergy. Repeated overexposure to Carbaryl can increase sensitivity to the acute effects. _______________________________________________________________ SECTION VII - HAZARDOUS INGREDIENTS
___________________________________________________________________________ INGREDIENT CONCENTRATION
TOXICITY
ORAL/DERMAL LD50 & INHALATION LC50
____________________________________________________________________________
ORAL: Rat >5,000 mg/kg
DERMAL:Rabbit 2,000 mg/kg
INHAL: Rat (4hr.) 0.72 mg/L
CAS NAME: N-[(trichloromethyl)thio]-4-cyclohexene-1,2-dicarboximide
CARBARYL
ORAL: Rat 264 mg/kg bw
DERMAL: Rabbit >2,000 mg/kg
INHAL: Rat (4hr.)2.5 mg/L.
CAS NAME: 1-naphthalenyl methylcarbamate
MALATHION 4.0
ORAL: Rat 2,800 mg/kg bw
DERMAL: Rabbit >4100 mg/kg
INHAL: Rat (4hr.) 84.6 mg/m³
CAS NAME: diethyl mercaptosuccinate, S-ester with O,O-dimethyl phosphoro-dithioate.
THIOPHANATE METHYL 3.0
ORAL: Rat - 6,640mg/kg
DERMAL: Rat >10,000 mg/kg
INHAL: Rat - 1,700 mg/m³/4H
CAS NAME: Dimethyl [1,2-phenylenebis(iminocarbonothioyl)]bis[carbamate].
MINERAL CARRIER
__________________________________________________________________________ SECTION VIII - PRECAUTIONS
___________________________________________________________________________ PERSONAL PROTECTIVE EQUIPMENT:
EYE CONTACT:
Wear safety glasses or goggles when direct exposure to product, dust is likely. SKIN CONTACT:
Wear full length work clothing, enclosed boots, and a hat. Wear neoprene gloves and an apron if direct contact with the product is likely. INHALATHION:
Use a dust mask or pesticide respirator if ventilation is not adequate.

WORKER PROTECTION
: Control skin and breathing exposure to avoid allergies. Ensure work areas have
ventilation, containment, and procedures sufficient to keep ingredients below the TLV levels in air. Provide separate
washing and eating facilities. Develop written safety and inspection procedures.
ENVIRONMENTAL PROTECTION: Storage, work areas, equipment washing, and waste holding facilities
must have adequate containment to prevent environmental contamination. Keep out of water supplies, ground water
or open water. This product is toxic to bees and slightly toxic to fish and wildlife. KEEP OUT OF REACH OF
CHILDREN
and animals. Keep bystanders out of the area where dust drift may occur during application.
____________________________________________________________________________
SECTION IX - HANDLING AND STORAGE
____________________________________________________________________________
SPILL PROCEDURE: Wear proper protective clothing. Stop further release or spread of contamination.
Sprinkle water to control dust. Shovel or scoop large amounts of powder into a disposable container. Wash area with
detergent and water. On soils, skim off the upper contaminated layer and collect for disposal. Spread the remainder
out over a larger area. Check local spill reporting regulations.
WASTE DISPOSAL: Do not reuse containers. Rinse thoroughly three times, and dispose of containers in accord
with local regulations. Return reusable bulk containers for refill. Industrial/commercial waste may be handled at
licensed facilities only and may be disposed of by incineration or burial in an approved site. Waste shipments must be
securely packed and properly labelled. Only licensed carriers may be used, and proper documents must accompany the
shipment. This product is biodegradable.
HANDLING PROCEDURES: Stop work, remove protective equipment, and wash hands, face and arms before
eating, smoking, drinking, or comfort. Clean up spilled material immediately, and clean clothes, equipment, and work
area after use. Keep product, wash or rinse water, and contaminated materials out of water.
STORAGE: Store in original container only, in a well ventilated, cool, dry area set aside for pesticides. The storage
area should be lockable. Keep separate from other products, especially herbicides, to prevent cross contamination.
Rotate stock. Keep storage area clean and orderly.
SPECIAL SHIPPING INFORMATION: Ship and store away from food, feed, seed, cosmetics, and medical
supplies.
TRANSPORTATION OF DANGEROUS GOODS ACT CLASSIFICATION:
ROAD/RAIL
NOT REGULATED
REGULATED LIMIT:
(captan) 0.5 Kg
_________________________________________________________________________
SECTION X - PREPARATION INFORMATION
____________________________________________________________________________ The information and recommendations contained herein are based on information believed to be correct. However, no
guarantee or warranty of any kind, expressed or implied is made with respect to the information provided herein.
ISSUE DATE: 10/12/2012
REVISION NO: N/A

PREPARED BY: Technical Department

Source: http://www.kinghg.on.ca/MSDS/English/2013MSDS/MSDS%2020057%20Gardal.pdf

ravnah.org

What Is Cholesterol-Lowering Medicine? If your doctor has decided that you need to take medicine to reduce high cholesterol, it’s because you’re at high risk for heart disease or stroke. Usual y the treatment combines diet and medicine. Most heart disease and many strokes are caused by a buildup of fat, cholesterol and other substances cal ed plaque in the inner wal s of your arteries. The

Jetplet24_00iskhakovlo

JETP Letters, Vol. 72, No. 12, 2000, pp. 603–607. Translated from Pis’ma v Zhurnal Éksperimental’noœ i Teoreticheskoœ Fiziki, Vol. 72, No. 12, 2000, pp. 872–878. Original Russian Text Copyright © 2000 by Iskhakov, Komogortsev, Moroz, Shalygina. Ch

Copyright © 2018 Predicting Disease Pdf